Drugs that contain Dronabinol

1. List of Syndros drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9345771 BENUVIA Oral cannabinoid formulations
Aug, 2028

(5 years from now)

US8222292 BENUVIA Liquid cannabinoid formulations
Aug, 2028

(5 years from now)

US10265293 BENUVIA Oral cannabinoid formulations
Aug, 2028

(5 years from now)

US11253472 BENUVIA Oral cannabinoid formulations
Aug, 2028

(5 years from now)

Do you want to check out SYNDROS patents from before 2022?

Market Authorisation Date: 23 March, 2017

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of SYNDROS before it's patent expiration?
More Information on Dosage

SYNDROS family patents

8

United States

1

Canada

1

Japan

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic